Construction of a two-gene prognostic model related to ferroptosis in renal cell carcinoma.

Li, Lei; Xu, Yawei; Yang, Wuping; Zhang, Kenan; Zhang, Zedan; Zhou, Jingcheng; Gong, Yanqing; Gong, Kan

Li, Lei; Xu, Yawei; Yang, Wuping; Zhang, Kenan; Zhang, Zedan; Zhou, Jingcheng; Gong, Yanqing; Gong, Kan.

Afiliación

Li L; Department of Urology, Peking University First Hospital, Beijing, China.
Xu Y; Institution of Urology, Peking University, Beijing, China.
Yang W; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, China.
Zhang K; National Urological Cancer Center, Beijing, China.
Zhang Z; Department of Urology, Peking University First Hospital, Beijing, China.
Zhou J; Institution of Urology, Peking University, Beijing, China.
Gong Y; Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, China.
Gong K; National Urological Cancer Center, Beijing, China.

Transl Androl Urol ; 12(7): 1167-1183, 2023 Jul 31.

Article en En | MEDLINE | ID: mdl-37554538

Palabras clave

Renal cell carcinoma (RCC); drug sensitivity; ferroptosis-related genes (FRGs); prognosis; risk score

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Transl Androl Urol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google